15868958

Source:http://linkedlifedata.com/resource/pubmed/id/15868958

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007600, umls-concept:C0008838, umls-concept:C0069717, umls-concept:C0086418, umls-concept:C0087111, umls-concept:C0206664, umls-concept:C1522618
pubmed:issue	2A
pubmed:dateCreated	2005-5-4
pubmed:abstractText	Oxaliplatin and cisplatin are widely used in cancer chemotherapy, however, their clinical efficiency is often limited by the development of resistance.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8102988
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adaptor Proteins, Signal Transducing, http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/DNA Adducts, http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Glutathione, http://linkedlifedata.com/resource/pubmed/chemical/MLH1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/MSH2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/MutS Homolog 2 Protein, http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Organoplatinum Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53, http://linkedlifedata.com/resource/pubmed/chemical/cisplatin-DNA adduct, http://linkedlifedata.com/resource/pubmed/chemical/oxaliplatin
pubmed:status	MEDLINE
pubmed:issn	0250-7005
pubmed:author	pubmed-author:BeyerClausC, pubmed-author:DempkeWolframW, pubmed-author:FruehaufAngelikaA, pubmed-author:MuellerThomasT, pubmed-author:RennickeAnjaA, pubmed-author:SchmollHans-JoachimHJ, pubmed-author:VoigtWielandW
pubmed:issnType	Print
pubmed:volume	25
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1147-55
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15868958-Adaptor Proteins, Signal Transducing, pubmed-meshheading:15868958-Carrier Proteins, pubmed-meshheading:15868958-Cell Line, Tumor, pubmed-meshheading:15868958-Cisplatin, pubmed-meshheading:15868958-DNA Adducts, pubmed-meshheading:15868958-DNA Repair, pubmed-meshheading:15868958-DNA-Binding Proteins, pubmed-meshheading:15868958-Drug Resistance, Neoplasm, pubmed-meshheading:15868958-Glutathione, pubmed-meshheading:15868958-Humans, pubmed-meshheading:15868958-Inhibitory Concentration 50, pubmed-meshheading:15868958-Male, pubmed-meshheading:15868958-MutS Homolog 2 Protein, pubmed-meshheading:15868958-Neoplasm Proteins, pubmed-meshheading:15868958-Nuclear Proteins, pubmed-meshheading:15868958-Organoplatinum Compounds, pubmed-meshheading:15868958-Proto-Oncogene Proteins, pubmed-meshheading:15868958-Teratocarcinoma, pubmed-meshheading:15868958-Testicular Neoplasms, pubmed-meshheading:15868958-Tumor Suppressor Protein p53
pubmed:articleTitle	Resistance mechanisms following cisplatin and oxaliplatin treatment of the human teratocarcinoma cell line 2102EP.
pubmed:affiliation	Department of Medical Oncology and Hematology, Martin-Luther-University Halle/Saale, Ernst-Grube-Str. 40, D-06120 Halle/Saale, Germany.
pubmed:publicationType	Journal Article